Delisting risk
LNAI · NASDAQ · Biotechnology

Lunai Bioworks (LNAI)

Biomedical-AI analytics and zebrafish screening for preclinical discovery.

$2.33
Pre-market−0.10 (−4.12%)
At close$2.43(+13.02%)

In millions of USD, except per-share figures

In millionsQ2 FY23Dec 2023Q3 FY23Mar 2024Q4 FY23Jun 2024Q1 FY24Sep 2024Q2 FY24Dec 2024Q3 FY24Mar 2025Q4 FY24Jun 2025Q1 FY25Sep 2025Q2 FY25Dec 2025Q3 FY25Mar 2026
Revenue0000000000
Cost of revenue0000000000
Gross profit0000000000
495153544221
Research & development1100000000
4855444221
General & administrative0055444200
Other expenses004648000000
Operating income−4−9−51−53−5−4−4−2−2−1
0−5019−34−12350−1
Interest income0000000000
Interest expense0020000000
Other non-operating income050−3−93−5122−501
Income before tax−5−59−50−44−70−1273−2−3
Net income from continuing operations−5−59−50−44−70−1273−2−3
Net income−5−59−50−44−70−1273−2−3
EPS, basic−$5.52−$43.20−$31.04−$22.40−$3.20$0.09−$60.88$1.04−$0.61−$0.80
EPS, diluted−$5.52−$43.20−$31.04−$22.40−$3.20$0.09−$60.88$1.04−$0.61−$0.80
Weighted average shares, basic1123
Weighted average shares, diluted1123
EBITDA−4−59−48−44−70−1273−2−2
Depreciation & amortization0000000000
EBIT−4−59−48−44−70−1273−2−2